FNORRENOV financials
A multi-period view of the public annual-account figures reported for FNORRENOV, with comparable measures and links to available source documents.
Company overviewRegistry number
0793531561
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 28, 2026
Financial evidence
Latest movements for FNORRENOV
2025 versus 2024
- Operating line
- €25,016
- EBITDA
- €13,659
- Total assets
- €53,469
- Equity
- €42,034
+255.8%
+255.6%
-10.8%
+25.3%
EBITDA margin +54.6% · Equity ratio +78.6%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €25,016 | €13,659 | €53,469 | €42,034 | - |
| 202431 Dec 2024 | €7,032 | €3,841 | €59,966 | €33,537 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.